PREPAPATION AND EVALUATION OF VALSARTAN LOADED HYDROGEL BEADS by Saleem. M.A et al.
Saleem. M.A et al. IRJP 2012, 3 (6) 
Page 80 
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY 
www.irjponline.com  ISSN 2230 – 8407 
Research Article 
 
 
PREPAPATION AND EVALUATION OF VALSARTAN LOADED HYDROGEL BEADS 
Saleem. M.A
*, Murali YD, Naheed MD, Patel Jaydeep, Malvania Dhaval 
Department of Pharmaceutics, Luqman College of Pharmacy, Gulbarga-585 102 Karnataka, India 
 
Article Received on: 18/03/12 Revised on: 09/04/12 Approved for publication: 19/05/12 
 
*M.A.Saleem, Asst. Professor, Department of Pharmaceutics, Luqman College of Pharmacy, Gulbarga-585102 Karnataka, India  
E-mail: ssaleempharm@gmail.com 
 
ABSTACT 
Valsartan loaded gel beads were prepared using sodium alginate, sodium carboxy methyl cellulose and chitosan individually using cross linking agent and 
chitosan along with sodium alginate/sodium carboxy methyl cellulose by ionotropic gelation method. The prepared gel beads were enteric coated using ethyl 
cellulose by solvent evaporation. The preformulation study performed on combination of drug with polymers by Fourier-transform infrared spectroscopy 
suggested that drug and polymers were compatible. The surface morphology was studied by scanning electron microscopy revealed that spherical or disc shape 
hydrogel beads were formed with smooth/rough texture. All the prepared hydrogel beads were evaluated for particle size, drug entrapment efficiency and 
percentage yield. The mean particle size was between 560.23-869.47 µm and increased as the concentration of polymers was increased. The drug entrapment 
efficiency was more than 90%. All the hydrogel beads were evaluated for invitro swelling and invitro release study. All the hydrogel beads showed good 
swelling in phosphate buffer 6.8 pH up to 8 h maintaining the integrity of the formulation. The swelling index followed the rank order sodium carboxy methyl 
cellulose<sodium alginate<chitosan and also as the concentration of polymer increased there was decrease in swelling. The invitro release of valsartan from all 
the hydrogel beads was more than 80% extended up to 10h in a nearly controlled manner. The invitro release followed the same pattern of swelling and 
decreased as the concentration of polymer increased. Hence it could be concluded that valsartan enteric coated hydrogel beads prepared by using combination 
of chitosan along with sodium alginate and sodium carboxy methyl cellulose sustain the release of valsartan more than 10 h in a predetermined manner for the 
effective management of hypertension. 
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INTRODUCTION 
Over  the  decade,  controlled  delivery  and  site-specific  drug 
delivery  have  made  rapid  advances.  The  interest  of  using 
natural and chemically modified polysaccharides as a part of 
drug development has increased in the past two decades and 
great  attention  has  been  focused  on  biopolymer  based 
hydrogels  for  use  as  potential  carriers  in  controlled  drug 
delivery
1,2.  Hydrogels  are  three  dimensional,  hydrophilic 
networks  capable  of  imbibing  large  amount  of  water  or 
biological  fluids,  mimics  biological  tissues
3.    Numerous 
approaches  have  been  investigated  for  formulation  of 
controlled  release  dosage  forms  of  different  therapeutic 
agents  including  proteins,  peptides,  and  even  cells. 
Microencapsulation has become a common technique in the 
production of controlled release dosage forms utilizing toxic 
solvents
4.  The  polymeric  gel  beads  are  prepared  by  using 
number  of  natural,  biodegradable  polymers  using  nontoxic 
aqueous  solvents.  The  beads  are  discrete  spherical 
microcapsules that serve as the solid substrate on which the 
drug is coated or encapsulated in the core of the beads. Beads 
can provide sustained release properties with more uniform 
distribution  of  drugs  within  the  gastrointestinal  tract
5,6. 
Furthermore bioavailability of drugs formulated in beads can 
be enhanced. Consequently, much research efforts have been 
concentrated  on  the  development  of  hydrogel  beads  using 
natural polymers as they are derived from natural sources, do 
not require organic solvents and easily available and
7. Drug-
loaded hydrogel beads offer an inert environment within the 
matrix and encapsulation is usually achieved in a media free 
of  organic  solvents.  Hydrogels  of  alginates,  chitosan, 
carboxymethyl cellulose, carrageenan and natural gums are 
widely use for the encapsulation of drug and even cells
8. The 
natural polyelectrolyte in spite, having a property of coating 
on the drug core and acts as release rate retardants contains 
certain  anions  on  their  chemical  structure  which  forms 
meshwork structure by combining with the polyvalent cations 
and induce gelation
9. Alginate is a non-toxic, biodegradable, 
naturally  occurring  polysaccharide  obtained  from  marine 
brown algae and certain species of bacteria. Sodium alginate 
is a sodium salt of alginic acid a natural polysaccharide and a 
linear  polymer  Recently,  much  research  efforts  have  been 
concentrated to develop alginate beads loaded with various 
low  molecular  weight therapeutic  agents
10,11. Chitosan is  a 
biopolymer  which  could  be  used  for  the  preparation  of 
various  polyelectrolyte  complex  products  with  natural 
polyanions  such  as  xanthan,  alginate,  and  carrageenan
12. 
Chitosan-polyanions  complexes  have  been  widely 
investigated  for  the  applications  like  drug  and  protein 
delivery,  cell  transplantation,  enzyme  immobilization
13,14.  
Sodium CMC is a chemically modified biopolymer contains 
carboxylic groups which can be cross-linked with multivalent 
metal  ions  like  ferric/aluminum  salt  with  chitosan  to  get 
biodegradable  hydrogel  beads  used  as  release  retardants. 
Controlled release pattern can also be improved by coating 
these hydrogels with chitosan/gelation and by cross-linking
15. 
Valsartan is a specific angiotensin II antagonist used alone or 
with  other  antihypertensive  agent  in  the  management  of 
cardiovascular complications. The terminal elimination half 
life is about 5-9 h. The oral dose is from 40 to 160 mg in 
divided doses, commercially available as 40 mg, 80 mg and 
160 mg tablet. Valsartan is poorly water soluble drug belongs 
to BCS-II category and particularly absorbed from alkaline 
pH
16,17. Valsartan was reported as orodispersible tablets and 
as film coated tablets
18,19. 
In the present work enteric coated valsartan loaded hydrogel 
beads were prepared using hydrogel forming polysaccharides 
lie  chitosan,  sodium  alginate  and  sodium  CMC  by  simple 
ionic gelation method for prolonged release of  valsartan in 
effective and safe management of cardiovascular diseases. 
MATERIALS AND METHODS 
Materials 
Valsartan  was  obtained  as  a  gift  sample  from  Dr  Reddy’s 
pharmaceuticals Hyderabad; chitosan was obtained as a gift 
sample from Indian sea foods Kochi, Kerala. Sodium alginate Saleem. M.A et al. IRJP 2012, 3 (6) 
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and sodium carboxy methyl cellulose (sodium CMC), ethyl 
cellulose  (EC)  and  sodium  tripolyphosphate  (STTP)  was 
purchased  from  S.D  Fine  chem.  Ltd.,  Mumbai.  All  other 
chemicals were analytical grade used directly as supplied by 
the manufacture. 
Preparation of valsartan loaded hydrogel beads 
Valsartan loaded hydrogel beads were prepared by ionotropic 
gelation method
20 using hydrogel forming polysaccharides as 
shown  in  Table  1.  In  the  first  scheme  of  the  preparation, 
valsartan gel beads were prepared by using single polymer 
like  sodium  alginate,  sodium  CMC  and  chitosan.  For  the 
preparation  of  sodium  alginate  and  sodium  CMC,  the 
polymer  was  dissolved  in  distilled  water  and  the  drug  in 
sodium lauryl sulphate (SLS) was added mixed thoroughly 
which  was  used  as  dope.  The  drug  polymer  solution  was 
dropped  through  syringe  having  24  gauze  needle  into  2% 
w/w of aluminium chloride solution. The obtained gel beads 
were kept overnight and then filter, washed and dried at room 
temperature.  For  chitosan  gel  beads,  the  polymer  was 
dissolved  in  1%  v/v  acetic  acid  and  the  drug  in  SLS  was 
added,  then  drug  polymer  solution  was  dropped  into  5% 
STTP solution. In the second scheme of preparation, sodium 
alginate and sodium CMC along with drug was used as dope 
where as chitosan in different concentration along with 2% 
aluminium chloride was used as coagulation medium. In the 
third  scheme  combination  of  sodium  alginate  with  sodium 
CMC  along  with  the  drug  was  used  as  dope  and  the 
coagulation medium was same as that in the second scheme. 
The pH of coagulation medium was adjusted to 4 using 0.1M 
HCl or NaOH during preparation of gel beads. 
Enteric coating of prepared hydrogel beads  
Hydrogel beads were coated with ethyl cellulose using oil-in-
oil solvent evaporation. Accurately weighed hydrogel beads 
were  dispersed  in  10  ml  of  coating  solution  prepared  by 
dissolving 50 mg of ethyl cellulose in ethanol: acetone (2:1) 
which was poured in to liquid paraffin 70 ml containing 1% 
w/v  span  80  which  was  stirred  at  1000  rpm  at  room 
temperature  for  3  h.,  filtered,  washed  with  n-hexane  and 
dried. 
Characterization of valsartan hydrogel beads 
a) Scanning electron microscopy 
The surface morphology of the hydrogel beads was examined 
using  scanning  electron microscopy  (SEM  LEO  14  SSVP, 
Cambridge, UK). The samples were mounted directly  onto 
the SEM sample holder using double-sided sticking tape and 
were gold spray coated. 
b) Fourier-transformation infrared (FTIR) spectroscopy 
The  drug-polymer  and  polymer-polymer  interactions  were 
studied by FTIR spectrometer (Perkin-Elmer (spectrum-100) 
Japan).    2%  (w/w)  of  the  sample  (after  crushing  the  gel 
beads) with respect to potassium bromide was mixed, ground 
into  a  fine  powder  and  then  compressed  into  discs  in  a 
hydraulic press.  Each disc was scanned 16 times at 2 mm/ 
sec at a resolution of 4 cm
–1 using cosine apodization.  The 
characteristic peaks were recorded. 
Evaluation of valsartan hydrogel beads 
a) Particle size determination
 
Measurement  of  the  particle  size  distribution  and  mean 
diameter of hydrogel beads was carried out with an optical 
microscope.  Stage  micrometer  was  used  to  calculate 
calibration  factor.  10  deviation  of  stage  micrometer  was 
matched  with  the  deviation  of  ocular  disc  and  calibration 
factor  was  calculated.  The  particle  size  was  calculated  by 
multiplying  the  number  of  deviation  of  the  ocular  disc 
occupied  by  the  particle  with  calibration  factor.  Fifty 
randomly chosen hydrogel beads were taken to measure their 
individual size. 
b) Drug entrapment efficiency 
Accurately weighed hydrogel beads equivalent to 50 mg were 
suspended in 100 ml 6.8 pH phosphate buffer solution using 
100 ml volumetric flask and kept for 24 h. Next day it was 
stirred  for  5  min  and  filtered.    From  this,  further  suitable 
dilutions were made and the drug content analyzed by UV 
spectrophotometrically  at  250nm.  The  blank  solution  was 
prepared in the same manner as above using hydrogel beads 
without the drug. 
d) Invitro swelling study 
The swelling study of hydrogel beads was carried out in two 
aqueous media, pH 1.2 HCL buffer solution (initial 2 h) and 
6.8 phosphate buffer solution (next 6 h). Accurately weighed 
hydrogel  beads  were  immersed  in  25  ml  of  pH  1.2  HCL 
buffer solution, after 2 h the hydrogel beads were transferred 
to 25 ml of pH 6.8 phosphate buffer solution. At fixed time 
intervals,  the  hydrogel  beads  were  separated  from  the 
medium, immediately they were wiped gently with paper and 
weighed. The dynamic weight change of the hydrogel beads 
with respect to time was calculated according to the formula. 
Degree  of  swelling  =  (wet  weight  −  original  dry  weight/ 
original dry weight) × 100. 
e) Invitro release study 
Invitro  drug release  study  was  done  by  using  USP  type-II 
apparatus (USP XXIII Dissolution test apparatus)  using 900 
ml of 1.2 pH HCl buffer for first 2 h and phosphate buffer pH 
6.8 for 8 h as dilution medium maintained at 37 ± 0.5ºC and 
at  50  rpm.  Aliquot  (5  ml)  of  dissolution  medium  was 
withdrawn at different time intervals, filtered and analyzed 
spectrophotometrically  at  250  nm.  The  volume  withdrawn 
every time was adjusted with fresh buffer solution. 
RESULTS AND DISCUSSION 
In the  present  study  valsartan  loaded hydrogel  beads  were 
prepared  as  enteric  coated  system  to  achieve  site  specific 
drug delivery. The hydrogel beads were developed by simple 
ionotropic gelation technique and coated with ethyl cellulose 
by  oil-in-oil  solvent  evaporation.  All  the  polysaccharides 
used were polyelectrolyte polymers having charges on their 
structure, which on interaction with either metal ions or ionic 
salts (STTP) or interaction of cationic (( )
+ - 3 NH of chitosan) 
and anionic polymers (–COO
–of alginate or sodium CMC)  
resulted in formation of hydrogel beads. The FT-IR spectra of 
selected formulations are shown in Fig 1. The IR spectra of 
the  drug  give  rise  to  the  broad  peak  at  3750  cm
-1  due  to 
carboxylic moiety and also at 3566 cm
-1 with C-H absorption 
peaks at 3000 cm
-1 of aromatic and as well as aliphatic. The 
carboxylic acid C=O and amide C=O are seen at 1710 cm
-1 
and  1682  cm
-1.The  combination  of  drug  with  chitosan  or 
sodium  alginate  or  sodium  CMC  or  sodium  alginate  an 
sodium CMC showed broad hump from 3500 cm
-1 to 2910 
cm
-1 corresponding to the number of hydroxyl group present 
in  the  compound  as  well  as  carboxylic  acid  residue  and 
carbonyl residues of the drug. The carboxylic acid carbonyl 
groups give absorption peak at 1731 cm
-1 and amide carbonyl 
group  at  1602  cm
-1.  These  data  explained  confirms  that 
during the process of formulation drug and the polymer no 
chemical reaction has taken  place.  Also  FTIR  spectrum  of 
valsartan loaded chitosan-sodium alginate beads, the peak at 
1700  cm
–1in  sodium  alginate  spectra  was  couple  to  form 
broad  peak  at  nearby  2200  cm
–1  to  2400  cm
–1  and  FTIR 
spectrum of drug loaded chitosan- sodium CMC beads the 
peak  observed  at  1200  cm
–1  in  sodium  CMC  spectra  was Saleem. M.A et al. IRJP 2012, 3 (6) 
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shifted  to  750-800  cm
–1.  This  evidenced  the  formation  of 
strong polyelectrolyte complex between chitosan and sodium 
alginate or sodium CMC. The surface morphology of selected 
hydrogel  beads  is  represented  in  Fig  2.  The  chitosan  and 
sodium  CMC  hydrogel  beads  prepared  were  spherical  in 
shape where as sodium alginate hydrogel beads prepared with 
aluminum chloride were flattened, disc shaped with collapsed 
center and smooth surface having little pores as illustrated in 
figure 2. The chitosan-sodium CMC hydrogel beads prepared 
were spherical in shape, where the chitosan-sodium alginate 
hydrogel  beads  were  shown  flattened,  disc  shaped  with 
collapsed centre and smooth surface having little pores. The 
surface  layer  of  all  the  spheres  was  denser,  hence  in  the 
preparation  process,  anionic  polymer  diffused  from  the 
droplet  core  towards  the  gelling  solution  (coagulation 
medium) to form more heterogeneous structure. The particle 
size of the gel beads is depicted in Table 2. The bead size was 
influenced by the orifice of the needle, extrusion rate (which 
were kept constant), concentration of polymer, counter ions 
and the pH of the coagulation medium. The particle size was 
increased as the amount of polymer was increased. The size 
of chitosan and sodium CMC beads was more as compare to 
alginate  because  of  viscosity.  The  size  of  combination  of 
chitosan  with  sodium  alginate  and  sodium  CMC  was  also 
large due to increase in viscosity. The result of entrapment 
efficacy is presented in Table 2. The entrapment efficacy was 
exceeded 90% suggesting that the ionotropic gelation method 
was effective for the entrapment of valsartan. Concentration 
of polymer used and the concentration of chitosan used in the 
combination  formulation  had  a  significant  role  in  the 
entrapment  efficiency.  The  swelling  data  of  valsartan 
hydrogel beads is illustrated in Figure 3 & 4. The degree of 
swelling  was  mainly  affected  by  pH  of  dissolution  media, 
type  of  the  polymer,  pH  of  the  coagulation  media  and 
concentration  of  chitosan  used.  All  the  gel  beads  showed 
good swelling in pH 6.8 phosphate buffer. The mean swelling 
of chitosan beads was (F1 & F2) 332.48 & 302.30, sodium 
alginate beads (F3 & F4) was 340.52 &311.32 and sodium 
CMC beads (F5 & F6) was 490.34 & 405.49 respectively. 
The swelling followed the order of sodium CMC > sodium 
alginate  >  chitosan  and  swelling  was  decreased  as  the 
concentration  of  polymer  increased.  The  combination  of 
chitosan with sodium alginate (F7, F8) showed 276.65 and 
268.88 of swelling where as chitosan with sodium CMC (F9, 
F10)  showed  259.54,  263.34  of  swelling  after  8  h.  The 
combination  of  chitosan  with  sodium  alginate  and  sodium 
CMC (F11, F12) showed 368.88, 354.82% swelling after 8 
hrs. As the concentration of the chitosan was increased there 
was  decrease  in  swelling.  In  combination  formulations  of 
chitosan with alginate and sodium CMC, the deprotonation of 
chitosan weakens the extent of ionic interaction which leads 
to dissociation of complex and hence degree of swelling was 
increased. The invitro release of the valsartan from hydrogel 
beads  is  illustrated  in  Figure  5  &  6. There  was  negligible 
release of the drug in pH 1.2 HCL buffer for the first 2 h 
which was due to enteric coating. The invitro release in pH 
6.8  phosphate  buffer  from  chitosan  beads  (F1,  F2)  was 
90.42%, 88.91%, from alginate beads (F3, F4) was 86.73% & 
9023% and from sodium CMC beads was 83.86% & 87.21% 
respectively after 10 h. The increase in the concentration of 
polymer did not much affect the invitro release but as the 
concentration  was  increased  the  release  pattern  followed 
nearer  to  a  constant  release.  The  sodium  CMC  beads 
prolonged the release for more than 10 hrs because of the low 
swelling.    The  invitro  release  followed  the  rank  order 
according to  the  polymer  sodium  CMC<  sodium alginate< 
chitosan. The invitro release of valsartan from the beads of 
chitosan with sodium alginate or sodium CMC did not show 
much  sustains  behavior.    The  valsartan  beads  of  chitosan 
along with combination of sodium alginate and sodium CMC 
showed  up  to  90.98%  release  after  10  h.  Here  as  the 
concentration of chitosan increased there was only change in 
the pattern of release but the release of valsartan not much 
varied. The combination of chitosan with negatively charged 
polymers sodium CMC and sodium alginate may expect to 
form ionic complex which may alter the release pattern. The 
in  vitro  release  data  obtained  was  subjected  to  zero  order, 
first  order,  Higuchi  and  Korsmeyer-Peppas  in  order  to 
establish  the  drug release  mechanism  and  kinetics  of  drug 
release  from  valsartan  gel  beads.  The  goodness  of  fit  was 
evaluated using the regression coefficient ‘r’. The correlation 
coefficient ‘r’ value of kinetic model is summarized in Table 
3. The ‘r’ value obtained for the zero order release for most 
of the formulations suggested that the release obeyed nearer 
to zero order kinetic. The ‘r’ value obtained for first order 
release was high for those preparations which contain lesser 
amount of polymer suggesting the release followed first order 
kinetics. When the data was fitted to according to the Higuchi 
model there was high ‘r’ value indicating that release from 
gel beads followed diffusion mechanism because of the gel 
matrix  behavior  of  the  polymer  used.  In  order  to  define  a 
model which will represent a better fit for the release from 
beads,  the  in-vitro  release  data  was  further  fitted  to 
Korsmeyer-Peppas model which is generally used to analyze 
the  drug  release  mechanism  when  mo  than  one  type  of 
release  phenomenon  is  operational.  Good  linearity  was 
observed with high ‘r’ values with value of slope 0.5< n ≥1 
suggesting probable release by super case-II transport. 
CONCLUSION 
Hence the valsartan loaded hydrogel beads prepared by using 
combination  of  chitosan  with  sodium  alginate  and  sodium 
CMC  by  simple  ionotropic  gelation  and  coated  with  ethyl 
cellulose  as  a  site  specific  delivery  system  sustained  the 
release  of  valsartan  in  a  constant  manner  which  may  be 
helpful for effective management of cardiovascular diseases. 
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Table 1: Preparation of valsartan loaded hydrogel beads 
Ingredients (% w/w) 
Formulation code 
F1  F2  F3  F4  F5  F6  F7  F8  F9  F10  F11  F12 
Valsartan  0.5  0.5  0.5  0.5  0.5  0.5  0.5  0.5  0.5  0.5  0.5  0.5 
Sodium alginate  --  --  1  3  --  --  3  3  --  --  1.5  1.5 
Sodium CMC  --  --  --  --  1  3  --  --  3  3  1.5  1.5 
Chitosan  0.5  1  --  --  --  --  0.5  1  0.5  1  0.5  1 
Sodium lauryl sulphate  --  --  1  1  1  1  1  1  1  1  1  1 
Aluminum chloride  --  --  2  2  2  2  2  2  2  2  2  2 
Sodium tripolyphosphate  5  5  --  --  --  --  --  --  --  --  --  -- 
 
Table 2: Evaluation parameters of valsartan hydrogel beads 
Formulation code  Particle size (µm) 
(Mean±SD) (n=50) 
% Drug entrapment 
(Mean±SD) (n=3) 
F1  674.03±58.24  95.13±0.37 
F2  736.08±87.82  93.20±1.40 
F3  560.23±45.24  93.43±1.33 
F4  643.04±66.56  92.86±0.56 
F5  621.80±94.00  90.67±1.40 
F6  703.63±72.90  94.03±0.90 
F7  786.78±53.43  97.40±1.30 
F8  798.64±81.12  90.83±1.76 
F9  806.24±78.76  95.16±1.34 
F10  827.03±89.60  94.76±1.05 
F11  864.74±79.24  90.48±1.08 
F12  869.47±69.57  93.28±1.28 
 
Table 3: Regressional analysis of the invitro release data according to various release kinetic models 
FC  Zero order (r
2)  First order (r
2)  Higuchi (r
2) 
Korsmeyer-Peppas 
(r
2)  n-value 
F1  0.9720  0.9558  0.9039  0.9492  1.3494 
F2  0.9829  0.9586  0.9088  0.9695  1.2778 
F3  0.9585  0.9810  0.9623  0.9401  1.1889 
F4  0.9725  0.9612  0.9204  0.9592  1.2934 
F5  0.9809  0.9690  0.9280  0.9762  1.2183 
F6  0.9825  0.9539  0.9021  0.9790  1.2760 
F7  0.9675  0.9398  0.8820  0.9547  1.7050 
F8  0.9545  0.9708  0.9031  0.9360  1.5454 
F9  0.9650  0.9643  0.8981  0.9552  1.5204 
F10  0.9613  0.9594  0.8980  0.9311  1.6998 
F11  0.9707  0.9555  0.8969  0.9743  1.3905 
F12  0.9574  0.9629  0.9064  0.9539  1.3964 
FC= Formulation code Saleem. M.A et al. IRJP 2012, 3 (6) 
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Figure 1: FTIR specta of selected valsartan loaded hydrogel bead formulations 
 
 
Figure 2: Scanning electron micrograph of a) chitosan hydrogel beads b) sodium alginate gel beads c) chitosan-sodium alginate gel beads d) chitosan-
sodium CMC beads 
 
 
Figure 3: Swelling data of valsartan hydrogel beads F1, F2, F3, F4, F5 & F6 
 
 
Figure 4: Swelling data of valsartan hydrogel beads F7, F8, F9, F10, F11 & F12 
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Figure 5: Invitro release of valsartan from hydrogel beads F1, F2, F3, F4, F5 & F6 
 
 
Figure 6: Invitro release of valsartan from hydrogel beads F7, F8, F9, F10, F11 & F12 
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